Supplement maolactin FMR put to the test for aching joints and muscles
NCT ID NCT06444763
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a supplement called Maolactin FMR can help reduce chronic inflammation, muscle pain, and joint discomfort in generally healthy adults aged 45 and older. About 97 participants took the supplement or a placebo for 8 weeks. Researchers measured changes in blood inflammation levels, weight, and self-reported pain and mobility.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RDC Clinical Pty Ltd
Brisbane, Queensland, 4006, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a daily supplement combo ease joint pain and fatigue in midlife women?
- Could a daily supplement ease joint pain, fatigue, and sleep troubles in middle age?
- Ultrasound and blood markers may unlock personalized treatment for rare nerve disease
- Could plant oils be the key to softer knees?
- Your iPhone could help monitor psoriasis: new study tests smartphone tracking
- Protein and exercise combo tested to fight muscle loss in sick kids